多学科方法治疗老年血液恶性肿瘤-一个范式转变。

IF 2.7 3区医学 Q2 HEMATOLOGY

Current Hematologic Malignancy Reports Pub Date : 2022-02-01 Epub Date: 2022-01-13 DOI:10.1007/s11899-021-00646-0

Sarah A Wall, Erin Stevens, Jennifer Vaughn, Naresh Bumma, Ashley E Rosko, Uma Borate

{"title":"多学科方法治疗老年血液恶性肿瘤-一个范式转变。","authors":"Sarah A Wall, Erin Stevens, Jennifer Vaughn, Naresh Bumma, Ashley E Rosko, Uma Borate","doi":"10.1007/s11899-021-00646-0","DOIUrl":null,"url":null,"abstract":"Hematologic malignancies are most likely to present in the seventh and eighth decades of life. Continued population growth will lead to increasing numbers of older adults with hematologic malignancies. Oncology care for older adults is complex and must account for the effect of aging on disease biology and treatment tolerance. Multidisciplinary oncology care has been utilized in solid tumor oncology for decades, initially driven by the need for multi-modality treatment. In this review, we make the case for multidisciplinary oncogeriatric care for older adults with hematologic malignancies in order to best navigate the intersection of aging and blood cancer.","PeriodicalId":10852,"journal":{"name":"Current Hematologic Malignancy Reports","volume":"17 1","pages":"31-38"},"PeriodicalIF":2.7000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757625/pdf/","citationCount":"2","resultStr":"{\"title\":\"Multidisciplinary Approach to Older Adults with Hematologic Malignancies-a Paradigm Shift.\",\"authors\":\"Sarah A Wall, Erin Stevens, Jennifer Vaughn, Naresh Bumma, Ashley E Rosko, Uma Borate\",\"doi\":\"10.1007/s11899-021-00646-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hematologic malignancies are most likely to present in the seventh and eighth decades of life. Continued population growth will lead to increasing numbers of older adults with hematologic malignancies. Oncology care for older adults is complex and must account for the effect of aging on disease biology and treatment tolerance. Multidisciplinary oncology care has been utilized in solid tumor oncology for decades, initially driven by the need for multi-modality treatment. In this review, we make the case for multidisciplinary oncogeriatric care for older adults with hematologic malignancies in order to best navigate the intersection of aging and blood cancer.\",\"PeriodicalId\":10852,\"journal\":{\"name\":\"Current Hematologic Malignancy Reports\",\"volume\":\"17 1\",\"pages\":\"31-38\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2022-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757625/pdf/\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Hematologic Malignancy Reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11899-021-00646-0\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Hematologic Malignancy Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11899-021-00646-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 2

摘要

血液恶性肿瘤最有可能出现在生命的第七个和第八个十年。持续的人口增长将导致越来越多的老年血液恶性肿瘤患者。老年人的肿瘤护理是复杂的，必须考虑到衰老对疾病生物学和治疗耐受性的影响。多学科肿瘤治疗在实体肿瘤治疗中已经应用了几十年，最初是由多模式治疗的需求驱动的。在这篇综述中，我们为老年血液恶性肿瘤患者提供多学科的老年肿瘤治疗，以便最好地把握衰老和血癌的交叉点。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Multidisciplinary Approach to Older Adults with Hematologic Malignancies-a Paradigm Shift.

查看原文本刊更多论文

Multidisciplinary Approach to Older Adults with Hematologic Malignancies-a Paradigm Shift.

Hematologic malignancies are most likely to present in the seventh and eighth decades of life. Continued population growth will lead to increasing numbers of older adults with hematologic malignancies. Oncology care for older adults is complex and must account for the effect of aging on disease biology and treatment tolerance. Multidisciplinary oncology care has been utilized in solid tumor oncology for decades, initially driven by the need for multi-modality treatment. In this review, we make the case for multidisciplinary oncogeriatric care for older adults with hematologic malignancies in order to best navigate the intersection of aging and blood cancer.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current Hematologic Malignancy Reports ONCOLOGY-HEMATOLOGY

CiteScore

6.00

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： his journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hematologic malignancy. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as leukemia, lymphoma, myeloma, and T-cell and other lymphoproliferative malignancies. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.